Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT07166354 | Clinical Study of mTOR Inhibitor as a Treatment for Grey Hair (Canities) | PHASE1 | NOT YET_RECRUITING | 100 | — | — | Oct 1, 2025 | Sep 15, 2027 | Sep 10, 2025 | - | — |
Greying Severity Score (GSS). Mild Greying score between 0-5, Moderate Greying score between 6-10 and Severe Greying score between 11-15
| Arm | Type | Description |
|---|---|---|
| CS-002 | EXPERIMENTAL | CS-002 Topical Treatment |
| Placebo | PLACEBO_COMPARATOR | Placebo Topical Treatment |
| Name | Type | Description |
|---|---|---|
| CS-002 | DRUG | CS-002 Topical Treatment |
| Placebo Topical Solution | DRUG | Placebo Topical Solution |
Inclusion Criteria: * Age 30 to 65 * Diagnosed with Grey Hair (Canities) * Willing and able to apply the treatment as directed, comply with study * Otherwise healthy * Able to give informed consent Exclusion Criteria: * A medical history that may interfere with study objectives * Women who are pr...